Gene Query: ARIH1

Dataset Description Geneva Score
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 38.33
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 24.9
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 23.28
Argonaute proteins couple chromatin silencing to alternative splicing 22.78
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 22.78
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 21.07
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 20.39
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 20.25
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 19.25
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 17.35
Role of XRN2 ribonucleolytic activity in RNA metabolism 16.82
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 16.77
Knockdown of ADNP in HCT116 colon cancer cells 15.85
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 15.43
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 15.43
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 15.12
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 14.97
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 14.97
RNAseq of HEK293 cells after Chtop knockdown 14.62
Co-transcriptional loading of RNA export factors shapes the human transcriptome 14.62
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 14.6
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 14.31
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 14.31
EWSR1 influences alternative splicing through direct and indirect mechanisms 14.3
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 14.05
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 14.05
Genes significantly down or Up-regulated upon RNF219 knockdown 13.95
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 13.54
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 13.19
Tracking of dCas9-methyltransferase footprints 13.12
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 13.01
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 13.01
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 12.71
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.57
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 12.33
SLAM-seq for K562 endogenous mRNA decay 12.01
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 11.95
Identification of transcription start sites for human A549 cell line using ReCappable-seq 11.72
circRNA-sequencing 11.36
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.27
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 11.17
Sensing self and nonself circular RNAs 11.06
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 11.01
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 11.0
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 10.87
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 10.57
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 10.46
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 10.46
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 10.42
RIG-I and MDA5 fRIP during KSHV lytic reactivation 10.35
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 10.24
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 10.21
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 9.94
Human cell line and subcutaneous tumor 9.92
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 9.82
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 9.81
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 9.81
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 9.75
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 9.64
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 9.64
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 9.6
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.6
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 9.48
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 9.44
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.43
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 9.42
Identification of global XBP1s target gene expression in human prostate cancer cells 9.35
Transcriptomic analyssis following EHMT1/2 inhibition 9.25
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 9.25
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 9.25
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 9.25
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 9.19
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 9.17
Characterization of parental and rociletinib-resistant derived H1975 cell lines 9.05
NKX2.2 9.04
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 9.04
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 9.03
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 8.93
Determination of tRNA aminoacylation levels by high throughput sequencing 8.88
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.86
Characterization of human ILC2 subsets 8.82
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 8.81
N6-methyladenine DNA Modification in Glioblastoma 8.81
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 8.75
Microprocessor mediates transcription termination in long noncoding microRNA genes 8.74
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 8.73
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 8.72
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 8.61
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 8.59
Transcriptome analysis of kidney organoids 8.55
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 8.51
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.44
3’ Uridylation Expands miRNA Target Repertoire 8.42
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 8.41
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 8.37
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.37
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 8.36
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 8.3
Transcriptome analysis in Neobractatin treated cells 8.29
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 8.21
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 8.16
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 8.14
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 8.14
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 8.14
MYC dependent mRNA translation shapes gene expression and cell biology 8.09
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 8.09
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.06
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 8.0
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 8.0
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 7.99
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 7.94
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 7.94
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 7.81
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 7.8
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 7.72
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 7.71
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 7.68
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 7.63
Transcription elongation regulates genome 3D structure 7.59
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 7.59
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 7.57
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 7.54
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 7.52
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 7.52
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 7.49
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 7.49
METTL3 promotes translation in human cancer cells 7.49
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 7.49
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 7.47
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 7.45
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 7.38
Systematic discovery of endogenous human ribonucleoprotein complexes 7.36
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 7.36
Effect of PBK knockdown on C4-2 cell transcriptome 7.34
Effect of BB608 on Gene Expression in HNSCC Cell Line 7.29
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 7.25
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 7.23
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 7.22
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.21
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 7.19
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 7.18
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 7.15
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 7.13
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.12
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 7.1
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 7.06
A transcriptome-wide divergence in protein translation scales with LIN28B expression 7.0
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 6.96
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 6.83
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 6.78
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.77
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.77
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.76
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 6.75
Global Mapping of Human RNA-RNA Interactions 6.74
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 6.73
Single-Cell Genotyping of Transcriptomes 6.68
RNA-seq of Single-Cell Genotyping of Transcriptomes 6.68
Peptidomimetic blockade of MYB in acute myeloid leukemia 6.63
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 6.63
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 6.62
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.6
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 6.58
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 6.57
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 6.57
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 6.53
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.51
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 6.51
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.49
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 6.48
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 6.46
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 6.46
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 6.39
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 6.33
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 6.32
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 6.32
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.29
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 6.27
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.25
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 6.25
Molecular Criteria for Defining the Naive Human Pluripotent State 6.24
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 6.2
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 6.17
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.12
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 6.06
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 6.03
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.99
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 5.92
Genome-wide functional assessment of enhancer activities in the human genome 5.9
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 5.85
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 5.85
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 5.79
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.79
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 5.64
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 5.62
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 5.59
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 5.56
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.55
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 5.5
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.48
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.48
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 5.48
CD86 regulates a pro-survival signal in myeloma cells 5.46
Biological effect of chronic mistranslation in mammalian cells 5.44
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 5.43
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 5.43
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.4
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.4
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.39
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.39
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 5.36
Co-regulation of splicing by Rbfox1 and hnRNP M 5.36
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.29
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.23
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 5.2
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.19
SLIGRL-induced gene expression changes in NHEK cells 5.17
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.17
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 5.14
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.08
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.08
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 5.01
4.99
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 4.98
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 4.98
Capturing the Interactome of Newly Transcribed RNA 4.98
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.98
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.93
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 4.93
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 4.91
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 4.9
RNA-Seq in neutrophils from Antiphospholipid Syndrome 4.88
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 4.87
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 4.84
High-throughput sequencing of PROMPT-enriched samples. 4.84
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 4.8
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 4.8
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.65
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 4.6
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 4.59
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 4.58
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 4.58
RNA-seq of RKO cells with cTAZ KO or putback 4.57
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.53
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.52
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 4.52
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.46
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 4.44
RNA-seq of naive and primed ES cells 4.4
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.39
An siRNA screen identifies CHD4 as a target for epigenetic therapy 4.31
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 4.27
X-Ray induced DNA-Hydroxymethylation changes 4.24
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.24
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.21
Transcriptomic analysis of the HOTAIR-regulated genes 4.2
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 4.19
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.18
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.17
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 4.09
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.06
RNAseq of cell lines with knocked in ESR1 mutations 4.05
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 4.04
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 4.03
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.01
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.0
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.96
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.96
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 3.94
Alteration of the microRNA network during the progression of Alzheimer’s disease 3.88
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 3.86
Recovery and analysis of nascent RNA 3.86
RNA transcriptome analysis during HSV-1 infection 3.83
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.8
Comparative Analysis of Cas9 Activators Across Multiple Species 3.8
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 3.78
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 3.75
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 3.7
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 3.7
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 3.69
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.68
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.68
Single-cell analysis of human kidney organoids 3.68
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 3.63
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.61
Gene expression in GBM with Cav3.2 inhibition 3.58
Role of COP1 on MAP kinase transcriptional output in melanoma 3.57
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 3.54
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 3.53
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.52
Functional significance of the HIV-1 Tat signature amino acid residues 3.41
RNA-sequencing in immortalized human mammary epithelial cells 3.41
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 3.41
Determining mRNA half-lives on a transcriptome-wide scale 3.38
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.35
UV_24h_GRO-Seq 3.35
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.3
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.29
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 3.28
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 3.27
The cohesin release factor WAPL restricts chromatin loop extension. 3.27
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.26
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 3.23
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 3.23
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 3.2
m6A-dependent regulation of messenger RNA stability 3.18
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.18
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.17
Identification of renal resident macrophages across species 3.11
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.07
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.03
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 3.02
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 2.99
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 2.99
RNA Sequencing of Human iPS derived Cardiomyocytes 2.97
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.93
Gene expression activation in CLL mediated by MSCs contact 2.91
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.91
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 2.9
RNAseq in Alzheimer's Disease patients 2.88
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.82
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 2.81
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.8
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.8
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 2.74
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.74
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 2.73
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.72
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 2.69
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 2.69
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.68
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.67
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.66
Aneuploidy triggers an immune response 2.65
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.63
STX4 Over-Expression in Human islets 2.63
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 2.6
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.57
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 2.56
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.56
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.53
The transcriptome effect of overexpressing EZH2 in MCF7 2.51
Effect of BMP inhibition or stimulation of primary human keratinocytes 2.5
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 2.5
oxLDL exposed trained monocytes 2.5
Transcriptomes of oxLDL exposed trained monocytes 2.5
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.5
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.47
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.45
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.44
Next generation sequencing of small RNAs isolated from exosomes in human semen 2.4
Effect of drugs on transcriptomic profiles 2.35
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.27
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.26
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.26
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.26
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.19
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.19
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.19
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.18
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.15
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.15
Identification of renal resident macrophages across species [C1] 2.15
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 2.14
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.11
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.09
Downregulation of DDX5/DDX17 and REST 2.04
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.03
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.02
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.02
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.01
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.98
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.94
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.91
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.9
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.89
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.88
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.85
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.83
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.81
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.78
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 1.78
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.78
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.75
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.72
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 1.71
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 1.71
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.69
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.68
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.62
Regulatory network controlling tumor-promoting inflammation in human cancers 1.62
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.6
Copper Regulation of HIF-1 Transcription Activity 1.6
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.56
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.56
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.56
Gene expression analysis of human hepatocellular cancers 1.55
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 1.5
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.47
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.44
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.43
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.42
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.42
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.41
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.34
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.29
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.27
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.27
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.27
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.25
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.25
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.25
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.25
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.22
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.2
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.2
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.19
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.19
Profiling of escape kinetics of viruses subjected to RNAi 1.19
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.18
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.18
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.18
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.14
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.1
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.1
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.09
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.09
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.06
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.06
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 1.01
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.01
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 1.0
In situ CAPTURE of chromatin interactions by biotinylated dCas9 1.0
RNA-Seq of PRMT1 overexpression ECA109 cells 0.99
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.92
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.92
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.92
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.9
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.9
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.87
Triple vectors expand AAV transfer capacity in the retina 0.87
Dilated cardiomyopathy vs Myocarditis 0.86
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 0.85
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 0.85
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.82
Modulation of nonsense-mediated decay by rapamycin 0.74
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.66
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.61
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.61
A code of mono-phosphorylation modulates the function of RB. 0.59
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.56
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.54
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.52
Dermal endothelial cells of type 2 diabetic patients 0.49
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.49
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.49
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.49
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.49
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.49
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.48
naive T cell heterogeneity after neonatal thymectomy 0.47
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.46
Aging-associated patterns in the expression of human endogenous retroviruses 0.43
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.4
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.4
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.33
Transcriptomic profiling of human peripheral blood-derived mast cells 0.33
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.33
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.33
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.33
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.28
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.28
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.28
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.26
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.24
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.24
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.22
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.22
NHLRC1 re-expression in cancer cells 0.21
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.2
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 0.19
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.19
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.18
Human Tfh cell RNA bulk sequencing 0.17
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.16
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.15
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.15
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.14
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.14
Transcriptome analysis of CNS leukemia 0.14
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.12
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.09
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.08
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.07
A single-cell transcriptome atlas of the human pancreas 0.07
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.05
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.05
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation